Archive - The M&A Hunter

JPM 2026 - DAY 1 REVIEW

Monday, January 12, 2026

11 hrs ago • The M&A Hunter

JPM Week 2026: The Biotech Dealmaking Superbowl Kicks Off Monday

January 10, 2026

Jan 10 • The M&A Hunter

GLSI Deep Dive: The Breast Cancer Vaccine

Jan 8 • The M&A Hunter

Our Regional Bank Plays

Jan 5 • The M&A Hunter

The Education of Oil

Not All Oil Is Born the Same

Jan 5 • The M&A Hunter

SUNDAY NEWS — January 4, 2026

New Rules, Crazy World, & A Nice Squeeze

Jan 5 • The M&A Hunter

American Greed Ended. Then the Next Episode Started.

A late-night tale of gold, AI, blockchain, and the audacity of media buying

Jan 4 • The M&A Hunter

The Reverse Split Escape Hatch Just Closed — What Micro-Cap Biotech Investors Need to Know

New SEC-approved rules effective January 1, 2026 fundamentally change the risk profile of sub-$1 stocks

Jan 4 • The M&A Hunter

JPM 2026 Newsletter — PART 3

Founder Pedigrees | PDUFA Dates | Exit Scenarios January 2, 2026

Jan 3 • The M&A Hunter

The J.P. Morgan Healthcare Conference

Our Holdings on Deck January 1, 2026

Jan 2 • The M&A Hunter

JPM Healthcare Conference 2026 — Part 1

The Super Bowl of Biotech 🏈💊

Jan 1 • The M&A Hunter

December 2025

Meta Made $16 Billion Helping Scammers Rob You

And they disbanded the team trying to stop it

Dec 29, 2025 • The M&A Hunter

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts